BTF acquired by bioMerieux

Friday, 14 September, 2007

Australian company BTF Decisive Microbiology has been acquired by bioMerieux. French clinical diagnostics company bioMérieux is present in more than 150 countries through 35 subsidiaries and has a large network of distributors.

The new acquisition will make BTF's products more accessible to a wider distribution network.

Initially, BTF will operate as a standalone subsidiary, so all existing customers will not see any changes in the short term. BTF's contact details remain unchanged.

Vaxxas appoints former Merck Global Vaccines President David Peacock as CEO

To lead the commercialisation of Vaxxas's proprietary high‑density microarray patch (HD‑MAP)...

Optics11 Life appoints Jacquelien ten Dam as CEO

Optics11 Life plans to accelerate its commercial growth in key markets while building strategic...

Epilepsy pioneer elected President of Aust Academy of Science

Laureate Professor Sam Berkovic — one of the world's most respected neurologists...

Content from other channels on our network

Greener method recovers critical metals from spent batteries

$70m investment to accelerate energy transition

Floating desalination solution to combat water scarcity

Tangkam BESS project gets grid connection approval

National solar panel recycling pilot program welcomed

Novel network cuts latency and energy use in smart factories

Researchers develop new process to recover metals from spent batteries

Fortescue's Elysia expands battery intelligence capability with US acquisition

The US market opportunity Australian engineering firms need right now

ACSC releases OT connectivity principles to set a higher security bar for organisations

Novel food processing technologies retain more nutrients in food

SA Wine Recovery Program extended until 2027

Shaking up machine changeover times on cartoning line

Five trends set to shape Australia's food & beverage industry in 2026

Foreign body inspection as a food safety measure in infant nutrition